Novel Pharmaceutical Approaches in Dementia

Integrating Armchair, Bench, and Bedside Research for Behavioral Neurology and Neuropsychiatry: Editorial

“…Furthermore, the link between air pollution and the pathogenesis of depression has been proven [ 53 ]. Novel therapeutics for neuropsychiatric conditions are under extensive study [ 54 , 55 ].…”

Neural Correlates and Molecular Mechanisms of Memory and Learning

“…Neuropharmacological research is critical for this multidisciplinary endeavor. The investigation of how drugs and compounds interact with complex neural networks found in preclinical models allows for a better understanding of potential therapeutic agents [ 90 , 91 , 92 , 93 ]. These findings will help guide the future development of pharmacological interventions targeting specific molecular pathways implicated in neuropsychiatric disorders [ 94 , 95 ].…”

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer’s disease: A systematic review and meta-analysis

“…Despite significant advances in our understanding of the CNS structure and function, the discovery and clinical development of novel medications for many CNS disorders has proven difficult. [53][54][55][56][57][58] Alzheimer's disease is a CNS disorder that worsens over time. 59,60 The diagnosis of AD relies mainly on behavioral assessment.…”